Castleman Disease Treatment Market To Upscale Based On Innovation

Posted by Steve Sharma on May 4th, 2022

The Castleman Disease Treatment Market is likely to grow voraciously, i.e. at a CAGR of xx% between 2017-2025, reaching 2x. Augmented and virtual reality are abreast with advanced technologies on a significant count. VR and AR do have loads of potential for offering in the healthcare vertical. The application areas include surgery and training simulation, and patients care and treatment.

Castleman disease is a rare condition of lymph nodes and similar tissues. This condition occurs when too many non-cancer cells started to grow in the lymph node. After initial growth hard growth started to form. Usually, it occurs in the chest, abdomen or neck. This condition is also called as angiofollicular lymph node hyperplasia. There are no known risk factors for castleman disease, but it usually occur in adults with weakened immune system.

There are two types of castleman disease unicentric and multicentric. Unicentric castleman disease affects only a single area or group of lymph nodes while multicentric castleman disease can affect lymphoid tissues around the body. Castleman disease is not life threatening except for the HIV-associated multicentric castleman disease